Full history for every metric is available with a Kvantra account
Stock profile
Derma Sciences, Inc. (DSCI)
Current price
7.00 USD0.00%
Last close 23 Feb 2017Benchmarks
Key financial summary
Financials in USD| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | $bn | 56 | 0 | 73 | 80 | 84 | 0 | 0 |
| Operating profit | $bn | -0 | - | |||||
| Net profit | $bn | -2 | -0 | -12 | -24 | -40 | -0 | - |
| EPS reported | $ | -1.47 | - | |||||
| Operating cashflow per share | $ | - | -1.37 | |||||
| Capex per share | $ | - | 0.07 | |||||
| FCF per share | $ | - | -1.44 | |||||
| Free cash flow | $bn | -0 | -0 | |||||
| Net debt | $bn | -0 | 8 | |||||
| Book value equity | $bn | 0 | 0 | |||||
| Book value per share | $ | 3.80 | 4.27 | |||||
| Number of shares | m | 25.9 | 26.34 | |||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | 1.20 | 1.84 | |||||
| P/S LTM | x | 1.40 | 0.00 | |||||
| P/FCF LTM | x | -3.18 | 0.00 | |||||
| EV/EBITDA LTM | x | -2.83 | 0.42 | |||||
| EV/Sales LTM | x | - | -0.18 | |||||
| Earnings Yield LTM | % | - | -21.02% | |||||
| FCF Yield | % | -31.46% | - | |||||
| Quality | ||||||||
| ROE | % | - | -0.06% | |||||
| ROIC | % | - | -19.54% | |||||
| Operating margin | % | - | -26.00% | |||||
| Gross margin | % | - | 38.75% | |||||
| FCF/Sales | % | - | -44.08% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | - | |||||
| Sales Growth YoY | % | -99.90% | -99.84% | |||||
| Net Income Growth YoY | % | - | - | |||||
| FCF Growth | % | - | - | |||||
| Operating Profit Growth | % | - | - | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | - | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | - | 0.00% | |||||
| FCF/Debt | x | -87.11 | -0.01 | |||||
| Net Debt/EBITDA | x | - | 0.42 | |||||
| EBIT/Net interest | x | - | 0.00 | |||||
| Net debt/market cap | % | -34.13% | - | |||||
| Net debt/Equity | x | -0.41 | 72.90 | |||||
| Gross debt/equity | x | 0.00 | 73.27 | |||||
Company overview
No description available.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
DS
Derma Sciences, Inc. (DSCI)
DSCI · NASDAQ · Healthcare
7.00 USD0.00%
Benchmarks
Financialsin USD
20142015TTM
Total revenue $bn8400
Operating profit $bn-0-
Net profit $bn-40-0-
EPS reported $-1.47-
About
No description available.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free